Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Operating cash flow minus capital expenditures
Latest
$-27.43M
↓ 11% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-24.63M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-27.43M | +30.4% |
| 2024 | $-39.43M | +29.0% |
| 2023 | $-55.57M | -60.2% |
| 2022 | $-34.69M | -39.4% |
| 2021 | $-24.88M | -30.3% |
| 2020 | $-19.09M | -21.5% |
| 2019 | $-15.71M | -66.7% |
| 2018 | $-9.43M | -1.9% |
| 2017 | $-9.25M | +14.9% |
| 2016 | $-10.87M | - |